24
May
2018
15:15
BST
Live Stream
Anti-Thrombotic Regimens for Patients With Atrial Fibrillation Following PCI: A New Era
-
Views:
1353
-
Likes:
0
Overview
Join Professor Nickenig and Dr Berg live from Paris as they discuss the latest data presented at euroPCR on anti-thrombotic regimens for patients with Atrial fibrillation following PCI, and how it may impact clinical practice.
Faculty:
Prof Georg Nickenig
Jur ten Berg
This interview is funded through an unrestricted educational grant by Boehringer Ingelheim.
Key Learning Objectives
This live stream is to inform and educate on:
- New data released at euroPCR on anti-thrombotic regimens for patients with Atrial fibrillation following PCI
- Dual vs. triple therapy and considerations for different patient sub-groups including ACS vs non-ACS, drug-eluting vs. stents, and renal function
- How new data may impact clinical practice or current guidelines
Target Audience
- Cardiologists
- Interventional Cardiologists
- Electrophysiologists
Faculty Biographies
Prof Georg Nickenig
Dr Georg Nickenig is a Full Professor and Chair, Department of Internal Medicine and Polyclinic II, University Hospital Bonn, Germany.
Dr Nickenig completed his doctoral degree in Clinical Medicine from the University of Bonn.
Jur ten Berg
Prof Jur ten Berg is Head of the St Antonius Center for Platelet Function Studies at the St Antonius Hospital, The Netherlands, where he also serves as Director of the Cardiology Training Programme. He has published over 400 peer-reviewed articles.